Debbie Noble Lanham
Adult Health · Atlanta, GANPI 1346497294
Payments from drug & device makers
Across 121 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$329
- Amgen$281
- Lilly USA, LLC$215
- Novo Nordisk$209
- Dexcom, Inc.$184
- Sanofi-aventis U.S. LLC$175
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 14 | $329 |
| Amgen | 11 | $281 |
| Lilly USA, LLC | 13 | $215 |
| Novo Nordisk | 13 | $209 |
| Dexcom, Inc. | 4 | $184 |
| Sanofi-aventis U.S. LLC | 8 | $175 |
| Bayer | 2 | $152 |
| GSK | 9 | $137 |
| Pfizer | 7 | $131 |
| Exact Sciences | 6 | $113 |
| Abbott | 6 | $95 |
| Astellas Pharma US Inc | 4 | $91 |
| Idorsia Pharmaceuticals US Inc | 2 | $78 |
| AstraZeneca | 4 | $68 |
| Merck | 3 | $65 |
| Edwards Lifesciences | 2 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Boehringer Ingelheim | 2 | $34 |
| Medtronic | 1 | $34 |
| AbbVie | 1 | $30 |
| UCB, Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| BD | 1 | $17 |
| Gilead | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,638 in reported general payments places this provider in the 80th percentile of 577 adult health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $17,373 |
| Lagevrio (Eua)Molnupiravir | 25 | $13,612 |
| LinzessLinaclotide | 12 | $9,433 |
| PaxlovidNirmatrelvir/Ritonavir | 19 | $2,859 |
| Fluticasone Propionate | 135 | $1,357 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $870 |
| Azelastine Hcl | 32 | $713 |
| CefuroximeCefuroxime Axetil | 25 | $587 |
| Doxycycline Hyclate | 65 | $515 |
| Escitalopram Oxalate | 22 | $510 |
| Azithromycin | 102 | $322 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $294 |
| Atorvastatin Calcium | 24 | $288 |
| Fluoxetine Hcl | 15 | $213 |
| Omeprazole | 14 | $193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $209 | $17,37311 claims |
| MerckLagevrio (Eua) | $65 | $13,61225 claims |
| AbbVieLinzess | $30 | $9,43312 claims |
| PfizerPaxlovid | $131 | $2,85919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 577 adult health providers in Georgia.
Other adult health in Atlanta
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenina LagascaAtlanta$17K
- Caleb MagistroAtlanta$17K
- Charise GleasonAtlanta$14K
- Colleen LewisAtlanta$11K
- Dawnelle StedingAtlanta$9K
- Julie WebsterAtlanta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.